المؤلفون: Joice Huang, Irina Proskorovsky, Stanimira Krotneva, Huamao M. Lin, Hui Huang, Joseph W. Y. Lee, William Reichmann, David Kerstein, Karen L. Reckamp

مصطلحات موضوعية: Male, Alectinib, Lung Neoplasms, Anaplastic Lymphoma, Brigatinib, Carbazoles, 030204 cardiovascular system & hematology, 03 medical and health sciences, Organophosphorus Compounds, 0302 clinical medicine, Crizotinib, Piperidines, Refractory, Carcinoma, Non-Small-Cell Lung, hemic and lymphatic diseases, medicine, Humans, Anaplastic Lymphoma Kinase, Sulfones, 030212 general & internal medicine, Lung cancer, Proportional Hazards Models, Ceritinib, business.industry, General Medicine, Middle Aged, medicine.disease, respiratory tract diseases, Pyrimidines, Cancer research, Female, Non small cell, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e256651f60e808b13b4740f58cc48a44Test

المؤلفون: Maximilian Hochmair, Edward S. Kim, Corey J. Langer, Myung-Ju Ahn, Karin Holmskov Hansen, Howard West, Harry J.M. Groen, Dong Wan Kim, Rudolf M. Huber, Marcello Tiseo, David Kerstein, Scott N. Gettinger, D. Ross Camidge, Luis Paz-Ares, Natasha B. Leighl, Egbert F. Smit, William Reichmann, Sang-We Kim, Karen L. Reckamp

المصدر: Huber, R M, Kim, D-W, Ahn, M-J, Langer, C J, Tiseo, M, West, H, Groen, H J M, Reckamp, K L, Hochmair, M J, Leighl, N B, Holmskov Hansen, K, Gettinger, S N, Paz-Ares, L G, Kim, E S, Smit, E F, Kim, S-W, Reichmann, W, Kerstein, D & Camidge, D R 2018, ' Brigatinib (BRG) in crizotinib (CRZ)-refractory ALK+ non–small cell lung cancer (NSCLC): Efficacy updates and exploratory analysis of CNS ORR and overall ORR by baseline (BL) brain lesion status ', Journal of Clinical Oncology, vol. 36, no. 15 Suppl., pp. 9061 . https://doi.org/10.1200/JCO.2018.36.15_suppl.9061Test

مصطلحات موضوعية: 0301 basic medicine, Oncology, Target lesion, Cancer Research, medicine.medical_specialty, Crizotinib, Brigatinib, business.industry, medicine.drug_class, non-small cell lung cancer (NSCLC), Exploratory analysis, medicine.disease, ALK inhibitor, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, Brain lesions, Cns disease, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2ebc8a387e1666ed1d4e6611308dc4dTest
https://portal.findresearcher.sdu.dk/da/publications/43007ce2-9e69-47b8-923e-9a50536ae6fdTest